Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07877 | 32325919 | Nutrients | Decreased Consumption of Added Fructose Reduces Waist Circumference and Blood Glucose Concentration in Patients with Overweight and Obesity. The DISFRUTE Study: A Randomised Trial in Primary Care. | 2020 | Details |
| A07878 | 32325806 | Toxins (Basel) | Development and Application of Extraction Methods for LC-MS Quantification of Microcystins in Liver Tissue. | 2020 | Details |
| A07879 | 32325349 | Biomed Pharmacother | Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis. | 2020 | Details |
| A07880 | 32325178 | J Ethnopharmacol | Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. | 2020 | Details |
| A07881 | 32324591 | Aging (Albany NY) | Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy. | 2020 | Details |
| A07882 | 32324317 | J Cell Mol Med | GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway. | 2020 | Details |
| A07883 | 32323426 | Hepatol Res | Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases. | 2020 | Details |
| A07884 | 32323349 | Aliment Pharmacol Ther | The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. | 2020 | Details |
| A07885 | 32323179 | Adv Exp Med Biol | Gut Microbiota and Liver Injury (II): Chronic Liver Injury. | 2020 | Details |
| A07886 | 32323115 | Eur J Epidemiol | Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population. | 2020 | Details |
| A07887 | 32322309 | Diabetol Metab Syndr | Effect of circulating exosomes derived from normal-weight and obese women on gluconeogenesis, glycogenesis, lipogenesis and secretion of FGF21 and fetuin A in HepG2 cells. | 2020 | Details |
| A07888 | 32322207 | Front Pharmacol | Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System. | 2020 | Details |
| A07889 | 32321858 | Gut | NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. | 2020 | Details |
| A07890 | 32321679 | Obes Res Clin Pract | Increased BMI 'alone' does not negatively influence sperm function - a retrospective analysis of men attending fertility treatment with corresponding liver function results. | 2020 | Details |
| A07892 | 32319718 | J Intern Med | Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. | 2020 | Details |
| A07893 | 32319693 | Hepatology | Epidemiology of Hepatocellular Carcinoma. | 2020 | Details |
| A07894 | 32318847 | Eur Radiol | Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C). | 2020 | Details |
| A07896 | 32318489 | J Family Med Prim Care | Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. | 2020 | Details |
| A07897 | 32317862 | Mediators Inflamm | Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. | 2020 | Details |
| A07898 | 32317687 | Sci Rep | Rebaudioside affords hepatoprotection ameliorating sugar sweetened beverage- induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07899 | 32317586 | Eur J Gastroenterol Hepatol | African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians. | 2021 | Details |
| A07900 | 32317584 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors. | 2021 | Details |
| A07901 | 32317079 | BMB Rep | GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress. | 2020 | Details |
| A07902 | 32316984 | BMC Health Serv Res | Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). | 2020 | Details |
| A07903 | 32316690 | Cells | Noninvasive Diagnosis of NAFLD and NASH. | 2020 | Details |
| A07904 | 32316419 | Int J Mol Sci | Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome. | 2020 | Details |
| A07905 | 32316235 | J Clin Med | The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis. | 2020 | Details |
| A07906 | 32315893 | Nutr Res | Siphonaxanthin, a carotenoid from green algae Codium cylindricum, protects Ob/Ob mice fed on a high-fat diet against lipotoxicity by ameliorating somatic stresses and restoring anti-oxidative capacity. | 2020 | Details |
| A07907 | 32315005 | Food Funct | Alleviating effects of noni fruit polysaccharide on hepatic oxidative stress and inflammation in rats under a high-fat diet and its possible mechanisms. | 2020 | Details |
| A07908 | 32314869 | J Cell Mol Med | Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. | 2020 | Details |
| A07909 | 32314395 | Lipids | High Glucose and Liver Fatty Acid Binding Protein Gene Ablation Differentially Impact Whole Body and Liver Phenotype in High-Fat Pair-Fed Mice. | 2020 | Details |
| A07910 | 32314167 | Indian J Gastroenterol | Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. | 2020 | Details |
| A07912 | 32312974 | Nat Commun | Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. | 2020 | Details |
| A07913 | 32312927 | Pol Przegl Chir | Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy. | 2019 | Details |
| A07914 | 32312689 | Best Pract Res Clin Obstet Gynaecol | Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. | 2020 | Details |
| A07915 | 32312347 | Public Health Nutr | Association between dietary sodium intake and non-alcoholic fatty liver disease in the US population. | 2020 | Details |
| A07916 | 32312333 | Br J Nutr | Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial. | 2020 | Details |
| A07917 | 32311490 | Free Radic Biol Med | Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. | 2020 | Details |
| A07918 | 32310756 | J Pharm Pharm Sci | Gamma glutamyl transferase - an underestimated marker for cardiovascular disease and the metabolic syndrome. | 2020 | Details |
| A07919 | 32309672 | Contemp Clin Trials Commun | Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. | 2020 | Details |
| A07920 | 32309365 | Ann Transl Med | Prolyl endopeptidase gene disruption attenuates high fat diet-induced nonalcoholic fatty liver disease in mice by improving hepatic steatosis and inflammation. | 2020 | Details |
| A07921 | 32309295 | Kidney Dis (Basel) | Plasma Metabolomics Profiling in Maintenance Hemodialysis Patients Based on Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry. | 2020 | Details |
| A07922 | 32308060 | Free Radic Res | Emerging connections between oxidative stress, defective proteolysis, and metabolic diseases. | 2020 | Details |
| A07923 | 32307859 | Hepatol Res | Non-invasive diagnosis of non-alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. | 2020 | Details |
| A07924 | 32306999 | BMC Res Notes | Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease. | 2020 | Details |
| A07925 | 32306666 | Zhonghua Gan Zang Bing Za Zhi | [Circadian clock and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07926 | 32306665 | Zhonghua Gan Zang Bing Za Zhi | [Assessment methods and research status of quality of life in patients with nonalcoholic fatty liver disease]. | 2020 | Details |
| A07927 | 32306658 | Zhonghua Gan Zang Bing Za Zhi | [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases]. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07929 | 32306653 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A07930 | 32306652 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases]. | 2020 | Details |
| A07931 | 32306651 | Zhonghua Gan Zang Bing Za Zhi | [Characteristics, diagnostic and therapeutic strategies for chronic hepatitis B combined with non-alcoholic fatty liver disease]. | 2020 | Details |
| A07932 | 32306650 | Zhonghua Gan Zang Bing Za Zhi | [Emphasis on clinical study of heterogeneity of non-alcoholic fatty liver disease]. | 2020 | Details |
| A07934 | 32306299 | Obes Surg | The Impact of Bariatric Surgery on Hepatic Function and Predictors of Liver Steatosis and Fibrosis. | 2020 | Details |
| A07935 | 32305562 | Cell Mol Gastroenterol Hepatol | SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells. | 2020 | Details |
| A07936 | 32305523 | Life Sci | Cystathionine gamma-lyase/H2S system suppresses hepatic acetyl-CoA accumulation and nonalcoholic fatty liver disease in mice. | 2020 | Details |
| A07937 | 32304992 | Int Immunopharmacol | Role of pyroptosis in liver diseases. | 2020 | Details |
| A07938 | 32304952 | Environ Pollut | Exposure to 2,3,3',4,4',5-hexachlorobiphenyl promotes nonalcoholic fatty liver disease development in C57BL/6 mice. | 2020 | Details |
| A07939 | 32304762 | Life Sci | ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. | 2020 | Details |
| A07940 | 32304142 | FASEB J | Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model. | 2020 | Details |
| A07941 | 32303531 | BMJ Open Diabetes Res Care | Tissue inhibitor matrix metalloproteinase 1 and risk of type 2 diabetes in a Chinese population. | 2020 | Details |
| A07942 | 32303415 | Eur J Surg Oncol | Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare? | 2020 | Details |
| A07943 | 32303170 | Curr Pharm Des | Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease. | 2021 | Details |
| A07944 | 32303161 | Curr Pharm Des | Semi-Quantitative Ultrasonographic Evaluation of NAFLD. | 2020 | Details |
| A07945 | 32303004 | Aging (Albany NY) | Ultraconserved element uc.333 increases insulin sensitivity by binding to miR-223. | 2020 | Details |
| A07946 | 32302970 | J Endocrinol | SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD. | 2020 | Details |
| A07947 | 32302728 | J Hepatol | Exercise retards hepatocarcinogenesis in obese mice independently of weight control. | 2020 | Details |
| A07949 | 32302265 | Circ Res | Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. | 2020 | Details |
| A07950 | 32301571 | Liver Int | Increasing liver fat is associated with progression of cardiovascular risk factors. | 2020 | Details |
| A07951 | 32301554 | Liver Int | What's in a name? Renaming 'NAFLD' to 'MAFLD'. | 2020 | Details |
| A07952 | 32301540 | FASEB J | Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner. | 2020 | Details |
| A07953 | 32301168 | Magn Reson Med | Free-breathing fat and R2 * quantification in the liver using a stack-of-stars multi-echo acquisition with respiratory-resolved model-based reconstruction. | 2020 | Details |
| A07954 | 32300995 | Hepatol Int | Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population. | 2020 | Details |
| A07955 | 32300166 | Sci Rep | Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity. | 2020 | Details |
| A07956 | 32299509 | BMC Res Notes | Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case-control study in Iran. | 2020 | Details |
| A07957 | 32299490 | BMC Res Notes | The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. | 2020 | Details |
| A07958 | 32299444 | Lipids Health Dis | MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line. | 2020 | Details |
| A07959 | 32298766 | J Hepatol | Lytic cell death in metabolic liver disease. | 2020 | Details |
| A07960 | 32298765 | J Hepatol | Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. | 2020 | Details |
| A07961 | 32298755 | Mol Cell Endocrinol | The offspring from rats fed a fatty diet display impairments in the activation of liver peroxisome proliferator activated receptor alpha and features of fatty liver disease. | 2020 | Details |
| A07962 | 32298459 | Histol Histopathol | Comparative analysis of the expression profiles of genes related to the Gadd45α signaling pathway in four kinds of liver diseases. | 2020 | Details |
| A07963 | 32298002 | Aliment Pharmacol Ther | Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome. | 2020 | Details |
| A07964 | 32297339 | Hepatology | Milk Fat Globule-Epidermal Growth Factor-Factor 8 Improves Hepatic Steatosis and Inflammation. | 2020 | Details |
| A07965 | 32297157 | Virol Sin | Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients. | 2020 | Details |
| A07966 | 32296880 | J Mol Med (Berl) | HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. | 2020 | Details |
| A07967 | 32295224 | Cells | Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis. | 2020 | Details |
| A07968 | 32295122 | Nutrients | Extra-Virgin Olive Oil from Apulian Cultivars and Intestinal Inflammation. | 2020 | Details |
| A07969 | 32294235 | Eur J Clin Invest | Macrophages in the pathophysiology of NAFLD: The role of sex differences. | 2020 | Details |
| A07970 | 32293522 | Trials | Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial. | 2020 | Details |
| A07971 | 32293289 | BMC Gastroenterol | The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease. | 2020 | Details |
| A07972 | 32293287 | BMC Gastroenterol | Combined effects of lifestyle risk factors on fatty liver index. | 2020 | Details |
| A07973 | 32293113 | J Cell Mol Med | Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways. | 2020 | Details |
| A07974 | 32292967 | Food Funct | DHA substitution overcomes high-fat diet-induced disturbance in the circadian rhythm of lipid metabolism. | 2020 | Details |
| A07975 | 32292439 | Pak J Med Sci | Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients. | 2022 | Details |
| A07977 | 32291579 | Indian J Gastroenterol | Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case series. | 2020 | Details |
| A07978 | 32291578 | Indian J Gastroenterol | Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. | 2020 | Details |
| A07979 | 32291277 | Diabetes Care | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes. | 2020 | Details |
| A07980 | 32290942 | Wei Sheng Yan Jiu | [Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats]. | 2020 | Details |
| A07981 | 32290895 | J Dev Orig Health Dis | Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease. | 2020 | Details |
| A07982 | 32290656 | J Agric Food Chem | Zinc Supplementation Alleviates Lipid and Glucose Metabolic Disorders Induced by a High-Fat Diet. | 2020 | Details |